Even with the S&P 500 hitting a new all-time intraday high, stocks still look attractive, said Wunderlich Securities' Art Hogan.
A look at luxury home markets seeing a boost, with Hessam Nadji, Marcus & Millichap.
The latest reading on luxury home prices shows a small increase compared to last year. CNBC's Diana Olick reports.
CNBC's Kate Rogers reports on where today's jobs are, from Salt Lake City, Utah.
Fred Yang, Hart Research, discusses the Wall Street Journal/NBC poll that showed Hillary Clinton has opened a 9-point lead on Republican challenger Donald Trump.
CNBC's John Harwood reports that the Donald Trump campaign plans to release its economic plan on Monday.
Shares of Bristol Myers Squibb are way down today while shares of Merck are up. Here's why, and what's next, with Tony Butler, Guggenheim Securities.
Where stocks can go from here, with Art Hogan, Wunderlich, and Kate Warne, Edward Jones.
It's been 5 years since S&P downgraded the U.S. credit rating. A look at the economic stats since then, with CNBC's Brian Sullivan.
CNBC's Carl Quintanilla looks at the lodging space for athletes at the Rio de Janeiro Olympics. The accommodations are getting mixed reviews. The NBA players are staying on a luxury cruise ship, in extremely nice accommodations.
The country's crumbling infrastructure may not be able to be fixed because of thousands of outdated local and state laws that prevent anything from getting done. Philip Howard, author and Common Good founder, explains.
Alibaba may be putting together a bid for Netflix, and Apple's looking for a few good hackers. Re/code's Ed Lee discusses.
CNBC Contributor Peter Costa discusses the day's market activity, and the impact of a strong jobs number.
What does a blowout jobs report mean for the election? Marc Morial, National Urban League, offers his analysis.
CNBC's Steve Liesman and Bill Rodgers, Rutgers University, discuss the jobs report and what it says about the U.S. economy.
CNBC's Steve Liesman looks at the blowout jobs report for July and what it says about the economy.
While Bristol Myers Squibb is having its worst day in nearly 16 years, shares of Merck is up 5 percent year over year. Nancy Tengler, Heartland Financial, discusses one of her largest holdings.
Bristol Myers Squibb is having its worst day in nearly 16 years after failing to meet goals for a lung cancer drug. Alex Arfaei, BMO, discusses.